[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

US20130274857A1 - Bifurcated side-access intravascular stent graft - Google Patents

Bifurcated side-access intravascular stent graft Download PDF

Info

Publication number
US20130274857A1
US20130274857A1 US13/906,247 US201313906247A US2013274857A1 US 20130274857 A1 US20130274857 A1 US 20130274857A1 US 201313906247 A US201313906247 A US 201313906247A US 2013274857 A1 US2013274857 A1 US 2013274857A1
Authority
US
United States
Prior art keywords
graft
stent
primary
sleeve
channel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/906,247
Inventor
Stephen F. Quinn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WL Gore and Associates Inc
Original Assignee
WL Gore and Associates Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/734,987 external-priority patent/US6645242B1/en
Priority claimed from US11/971,426 external-priority patent/US8556961B2/en
Application filed by WL Gore and Associates Inc filed Critical WL Gore and Associates Inc
Priority to US13/906,247 priority Critical patent/US20130274857A1/en
Publication of US20130274857A1 publication Critical patent/US20130274857A1/en
Priority to US17/100,345 priority patent/US20210068992A1/en
Priority to US17/482,120 priority patent/US20220008230A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/856Single tubular stent with a side portal passage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/89Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/061Blood vessels provided with means for allowing access to secondary lumens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/065Y-shaped blood vessels
    • A61F2002/067Y-shaped blood vessels modular
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/075Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2220/0075Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable

Definitions

  • the field of the present invention relates to intravascular stent grafts.
  • a bifurcated side-access intravascular stent graft and methods for fabricating and deploying the same are described herein.
  • vascular disease a damaged, weakened, and/or enlarged portion of a blood vessel must be protected from intravascular fluid pressure. Continued exposure to such fluid pressure may result in progression of damage to the affected area and/or vessel failure, accompanied by significant morbidity or even sudden death.
  • a well-established technique for treating such vascular damage is the use of transluminally-deployed stent grafts.
  • a stent graft comprises two major components, a stent and a graft.
  • the stent typically takes the form of a somewhat stiff tube-like structure inserted into an affected vessel and fixed in place.
  • the stent may serve to maintain a patent vessel lumen, may serve as structural support for the vessel, and/or may serve as an attachment/seal for a graft.
  • a graft typically takes the form of a flexible tube or sleeve which is at least somewhat fluid-tight (although varying degrees of permeability may be desirable for a variety of reasons).
  • the graft When secured within a vessel using stents (a single stent the length of the graft, a pair of stent segments at the ends of the graft, or multiple stent segments spaced along the length of the graft), the graft becomes a surrogate vessel-within-a-vessel, and bears the brunt of the intravascular fluid pressure. It has become common practice to bridge damaged vessel segment using a sufficiently long graft secured within the vessel with stent segments.
  • a bifurcated side-access intravascular stent graft and methods for fabricating and deploying the same wherein the stent graft may be deployed transluminally to repair vessels having large-angle branch vessels (ranging from about 0° up to about 180°, for example). It is therefore desirable to provide a bifurcated side-access intravascular stent graft and methods for fabricating and deploying the same, providing a substantially fluid-tight seal with the main vessel and the branch vessel. It is therefore desirable to provide a bifurcated side-access intravascular stent graft and methods for fabricating and deploying the same, wherein the stent graft may be deployed transluminally without distal access through the branch vessel. It is therefore desirable to provide a bifurcated side-access intravascular stent graft and methods for fabricating and deploying the same, wherein the stent graft may be readily and accurately positioned relative to the branch vessel.
  • FIG. 1 shows an isometric view of a primary stent graft according to the present invention.
  • FIG. 2 shows a front view of a primary stent graft according to the present invention.
  • FIG. 3 shows a side view of a primary stent graft according to the present invention.
  • FIG. 4 shows a transverse-sectional view of a primary stent graft according to the present invention.
  • FIG. 5 shows a transverse-sectional view of a primary stent graft according to the present invention.
  • FIG. 6 shows a transverse-sectional view of a primary stent graft according to the present invention.
  • FIG. 7 shows a transverse-sectional view of a primary stent graft according to the present invention.
  • FIG. 8 shows a longitudinal-sectional view of a primary stent graft according to the present invention.
  • FIG. 9 shows a longitudinal-sectional view of a primary stent graft according to the present invention.
  • FIG. 10 shows an isometric view of a bifurcated stent graft according to the present invention.
  • FIG. 11 shows a front view of a bifurcated stent graft according to the present invention.
  • FIG. 12 shows a side view of a bifurcated stent graft according to the present invention.
  • FIG. 13 shows a transverse-sectional view of a bifurcated stent graft according to the present invention.
  • FIG. 14 shows a transverse-sectional view of a bifurcated stent graft according to the present invention.
  • FIG. 15 shows a longitudinal-sectional view of a bifurcated stent graft according to the present invention.
  • FIG. 16 shows a procedure for deploying a primary stent graft according to the present invention.
  • FIG. 17 shows a procedure for deploying a secondary stent graft according to the present invention.
  • FIG. 18 shows a longitudinal-sectional view of a primary stent graft according to the present invention.
  • FIG. 19 shows a transverse-sectional view of a primary stent graft according to the present invention.
  • FIG. 20 shows a transverse-sectional view of a primary stent graft according to the present invention.
  • FIG. 21 shows a transverse-sectional view of a primary stent graft according to the present invention.
  • FIG. 22 shows a transverse-sectional view of a primary stent graft according to the present invention.
  • FIG. 23 shows a procedure for adapting an internal graft sleeve according to the present invention.
  • FIG. 24 shows a procedure for adapting an internal graft sleeve according to the present invention.
  • FIG. 25 shows a transverse-sectional view of a primary stent graft according to the present invention.
  • FIG. 26 shows a front view of a bifurcated stent graft according to the present invention.
  • FIG. 27 shows a side view of a bifurcated stent graft according to the present invention.
  • FIG. 28 shows a transverse-sectional view of a bifurcated stent graft according to the present invention.
  • FIG. 29 shows a transverse-sectional view of a bifurcated stent graft according to the present invention.
  • FIG. 30 shows a transverse-sectional view of a bifurcated stent graft according to the present invention.
  • FIG. 31 shows a transverse-sectional view of a bifurcated stent graft according to the present invention.
  • FIG. 32 shows a transverse-sectional view of a bifurcated stent graft according to the present invention.
  • FIG. 33 shows a transverse-sectional view of a bifurcated stent graft according to the present invention.
  • FIG. 34 shows a longitudinal-sectional view of a bifurcated stent graft according to the present invention.
  • FIG. 35 shows an isometric view of a primary stent graft according to the present invention.
  • FIG. 36 shows an isometric view of a bifurcated stent graft according to the present invention.
  • FIG. 37 shows a front view of a primary stent graft according to the present invention.
  • FIG. 38 shows a transverse-sectional view of a primary stent graft according to the present invention.
  • FIG. 39 shows a transverse-sectional view of a primary stent graft according to the present invention.
  • FIG. 40 shows a transverse-sectional view of a primary stent graft according to the present invention.
  • FIG. 41 shows a longitudinal-sectional view of a primary stent graft according to the present invention.
  • proximal shall denote the direction along a vessel system in which multiple smaller vessels come together to form a larger vessel
  • distal shall denote the opposite direction, i.e., the direction in which a larger vessel divides into multiple smaller vessels.
  • proximal therefore corresponds to “upstream”, while distal corresponds to “downstream”.
  • proximal therefore corresponds to “upstream”
  • distal corresponds to “downstream”.
  • a bifurcated intravascular primary stent graft 100 is illustrated in FIGS. 1-9 and comprises: a first primary stent segment 210 ; a second primary stent segment 220 ; a primary graft sleeve 200 having first open end 230 , having a second open end 240 , forming a main fluid flow channel 235 therebetween, and having a side opening 250 therethrough; and an internal graft channel 260 formed by partition 280 within the primary graft sleeve 200 and having an inner open end 270 within the primary graft sleeve 200 and an outer open end communicating with the side opening 250 of the primary graft sleeve 200 .
  • An internal stent segment 290 may be provided near the inner open end 270 of internal graft channel 260 , to keep internal graft channel 260 open and to facilitate later deployment of a secondary stent graft (described herein below).
  • the internal graft channel 260 and partition 280 thereby form at least a portion of a branch fluid flow channel between main channel 235 and the side opening 250 of the primary graft sleeve 200 .
  • Primary graft sleeve 200 may be operatively coupled near the first open end 230 to the first primary stent segment 210 and operatively coupled near the second open end 240 to the second primary stent segment 220 , so that stent segments 210 and 220 and graft sleeve 200 thereby form a single operative unit.
  • Each stent segment and the corresponding open end may preferably be adapted for engaging an endoluminal surface of a main vessel and forming a substantially fluid-tight seal therewith.
  • a bifurcated intravascular stent graft according to the present invention may comprise a primary stent graft 100 and may further comprise a secondary stent graft 300 as illustrated in FIGS. 10-15 .
  • the secondary stent graft 300 comprises: a first secondary stent segment 310 ; a second secondary stent segment 320 ; and a secondary graft sleeve 302 .
  • Secondary graft sleeve 302 may be operatively coupled near first open end 330 to the first secondary stent segment 310 and operatively coupled near second open end 340 to the second secondary stent segment 320 , so that stent segments 310 and 320 and secondary graft sleeve 302 thereby form a single operative unit.
  • Secondary stent 300 may be adapted to pass within internal graft channel 260 and through side opening 250 .
  • First stent segment 310 and corresponding first open end 330 may preferably be adapted for engaging an inner surface of internal graft channel 260 and forming a substantially fluid-tight seal therewith.
  • Second stent segment 320 and corresponding second open end 340 may preferably be adapted for engaging an endoluminal surface of a branch vessel and forming a substantially fluid-tight seal therewith. Secondary stent graft 300 may therefore form at least a portion of the branch fluid flow channel.
  • the stent graft of the present invention is particularly well-suited for repair of main vessel segments where a branch vessel leaves the main vessel at an angle approaching 90°.
  • Previous bifurcated stent graft devices enable repairs where a branch vessel leaves the main vessel at a substantially smaller angle of less than about 45°. This condition does not obtain at several potentially important vessel repair sites.
  • Other previous devices enable repair at such high-angled branches only when transluminal access to a distal portion of the branch vessel is possible. In many instances such access is either impossible (celiac artery, mesenteric arteries, renal arteries) or extremely difficult and/or dangerous (carotid arteries).
  • Still other previous devices do not provide a substantially fluid-tight seal with the branch vessel, thereby partially defeating the purpose of the stent graft (i.e., shielding the repaired portion of the main vessel and/or branch vessel from intravascular fluid pressure).
  • bifurcated primary stent graft 100 may be delivered transluminally to a repair site 30 of a main vessel 20 , and may be adjusted longitudinally and/or rotated about its long axis within the main vessel lumen until side opening 250 is substantially aligned with the lumen of branch vessel 40 .
  • Bifurcated primary stent graft 100 may be provided with one or more radiopaque markers or indexes to facilitate the alignment under fluoroscopic imaging.
  • First primary stent segment 210 and first open end 230 may be engaged with the endoluminal surface of a first segment of the main vessel 20 near the repair site to form a substantially fluid-tight seal
  • second primary stent segment 220 and second open end 240 may be engaged with the endoluminal surface of a second segment of the main vessel 20 near the repair site to form a substantially fluid-tight seal, thereby deploying bifurcated primary stent graft 100 within the repair site 30 of main vessel 20 .
  • Bifurcated primary stent graft 100 may be delivered through the main vessel from upstream or from downstream, as dictated by the particular clinical circumstances.
  • Secondary stent graft 300 is then delivered to the repair site and deployed, as illustrated in FIG. 17 .
  • Secondary stent graft 300 is delivered transluminally to the repair site and passed within internal graft channel 260 of primary stent graft 100 .
  • Secondary stent graft 300 may be delivered within the main vessel to the repair site from the same direction as primary stent graft 100 , or from the opposite direction if feasible and/or desirable. Delivery from the same direction as delivery of primary stent graft 100 within the main vessel may be preferred due to the preferred construction of internal graft channel 260 .
  • Secondary stent graft 300 may also be delivered from a distal point within the branch vessel 40 if feasible and/or desirable. Secondary stent graft 300 is positioned at least partially within internal graft channel 260 , passing through side opening 250 and into branch vessel 40 . Secondary stent graft 300 may be provided with one or more radiopaque markers or indexes to facilitate the positioning under fluoroscopic imaging.
  • First secondary stent segment 310 and first open end 330 may be engaged with the inner surface of the internal graft channel 260 to form a substantially fluid-tight seal
  • second secondary stent segment 320 and second open end 340 may be engaged with the endoluminal surface of the branch vessel 40 to form a substantially fluid-tight seal, thereby deploying secondary stent graft 300 within the internal graft channel 260 and the branch vessel 40 .
  • the first and second substantially fluid-tight seals of primary stent graft 100 and secondary stent graft 300 together substantially shield the main vessel walls and/or the branch vessel walls at the repair site from intravascular fluid pressure, while preserving fluid flow both through the main vessel and into the branch vessel.
  • incoming fluid flow may enter either open end 230 or 240 of bifurcated stent graft 100 and pass through main fluid flow channel 235 .
  • the incoming fluid flow Upon reaching the inner open end 270 of internal graft channel 260 , the incoming fluid flow divides into a portion continuing to flow in the main fluid flow channel 235 and a portion flowing through the branch fluid flow channel within internal graft channel 260 and through side opening 250 .
  • the fluid flow in main channel 235 continues out of bifurcated stent graft 100 and back into the main vessel 20 .
  • the branch fluid flow channel comprises a portion of internal graft channel 260 and the interior of secondary stent graft 300 , and the branch fluid flow passes into the open inner end 270 of internal graft channel 260 , into the open first end 330 of secondary stent graft 300 , through secondary stent graft 300 (and therefore through side opening 250 ), out of open second end 340 of secondary stent graft 300 , and into branch vessel 40 .
  • Stent graft 300 may preferably be made sufficiently flexible to be bent through angles ranging from about 0° through about 180° while still forming a portion of the branch fluid flow channel.
  • the bifurcated stent graft of the present invention may be used to repair main vessels near where branch vessels leave the main vessel at arbitrarily large angles, even approaching about 180°.
  • side opening 250 through primary graft sleeve 200 may be made substantially larger than the lumen, thereby increasing the range of positions of bifurcated primary stent graft 100 that nevertheless enable passing secondary stent graft 300 through side opening 250 and into branch vessel 40 .
  • internal graft channel 260 may increase in size with distance from inner open end 270 , so that the size of the open inner end of internal graft channel 260 may substantially match the size of secondary stent graft 300 and/or the lumen of branch vessel 40 , while the outer open end of internal graft channel 260 may substantially match the relatively enlarged size of side opening 250 .
  • any suitable configuration and/or materials may be employed for stent segments 210 , 220 , 290 , 310 , and/or 320 .
  • Many suitable configurations for intravascular stents have been developed over the years, as disclosed in the incorporated references and in references cited therein (U.S. Pat. Nos. 5,855,598 and 6,093,203 are of particular note for containing many examples).
  • Such stent configurations may include but are not limited to braids (open-lattice or closely-woven), helical structural strands, sinusoidal structural strands, mesh-like materials, diamond-shaped mesh, rectangular shaped mesh, functional equivalents thereof, and/or combinations thereof.
  • Materials should be sufficiently strong, bio-compatible, hemo9 compatible, corrosion-resistant, and fatigue-resistant, and may include metals, plastics, stainless steels, stainless spring steels, cobalt-containing alloys, titanium-containing alloys, nitinol, nickel-containing alloys, nickel-titanium alloys, composite materials, clad composite materials, other functionally equivalent materials (extant or hereafter developed), and/or combinations thereof.
  • a stent graft may typically be delivered transluminally to a vascular repair site with the stent segment in a radially compressed configurations having a delivery diameter sufficiently small to pass through any required vessels to the repair site. Once positioned properly, the stent segment may be radially enlarged to a deployed diameter.
  • the stent segment may be fabricated so that the delivery diameter is achieved through elastic radial compression of the stent segment (maintained during transluminal delivery by a sleeve or equivalent device). Once properly positioned, the sleeve or equivalent device may be removed, thereby allowing the stent segment to expand to its deployed diameter.
  • the deployed diameter may be smaller than the uncompressed diameter of the stent segment, so that residual elastic expanding force exerted by the stent segment may serve to hold the vessel open, fix the stent in place in the vessel, and/or form a substantially fluid-tight seal with the endoluminal surface of the vessel (in conjunction with a graft sleeve).
  • the stent segment may comprise material(s) that undergo plastic deformation.
  • the stent graft may be delivered transluminally with the stent segment having a delivery diameter sufficiently small to allow delivery to the repair site.
  • the stent segment may then be expanded (by an intra-luminal balloon catheter or other functionally equivalent device) to a deployed diameter, and may maintain the deployed diameter due to plastic deformation of the stent segment during expansion.
  • the expanded stent segment may serve to engage the endoluminal surface of the vessel to hold the vessel open, hold the stent graft in position, and/or form a substantially fluid-tight seal with the vessel.
  • Other methods of delivery and/or deployment may be employed without departing from inventive concepts disclosed and/or claimed herein.
  • the stent segment must be adapted to engage the endoluminal surface of the vessel. This may be accomplished by any suitable method (currently known or hereafter developed; for example as disclosed in the incorporated references and in references cited therein), including but not limited to: elastic or plastic expansion; sutures; ligatures; clips; barbs; endoluminal cellular overgrowth; functional equivalents thereof; and/or combinations thereof.
  • First and second stent segments corresponding to a single graft sleeve of a single stent graft have been shown herein as separate structural elements. Pairs of first and second stent segments (segments 210 and 220 , for example, or 310 and 320 ) may be mechanically connected by a stent coupling member. Three longitudinal wires 215 are shown serving to connect stent segments 210 and 220 of primary stent graft 100 , while longitudinal wires 315 are shown serving to connect stent segments 310 and 320 in FIGS. 32 , 33 , and 34 . Other functionally equivalent configurations may be employed without departing from inventive concepts disclosed and/or claimed herein.
  • first and second stent segments may comprise first and second ends of a single stent.
  • a single primary stent would require an side opening corresponding to side opening 250 of graft sleeve 200 .
  • No such side opening would be required for a single secondary stent comprising first and second segments 310 and 320 .
  • Such a single stent may be preferred for secondary stent graft 300 , since it is typically bent to enter a branch vessel but must nevertheless maintain an open branch fluid channel.
  • any suitable configuration and/or materials may be employed for primary graft sleeve 200 , partition 280 , and/or graft sleeve 300 .
  • Such sleeve materials may include, but are not limited to: continuous sheets; interwoven textile strands; multiple filament yarns (twisted or un-twisted); monofilament yarns; PET (Dacron), polypropylene, polyethylene, high-density polyethylene, polyurethane, silicone, PTFE, polyolefins, ePTFE, biologically-derived membranes (such as swine intestinal submucosa), functional equivalents thereof, and/or combinations thereof.
  • the graft sleeve may be delivered at the size appropriate for deployment at the repair site, or may be a smaller size and stretched (plastically deformed) at the repair site to the desired deployed size. Graft sleeves are shown herein outside the corresponding stent segment, but the stent segment may equivalently be outside the corresponding graft sleeve.
  • the graft sleeve and corresponding stent segment(s) may be operatively coupled by any suitable method (currently known or hereafter developed), including but not limited to: sutures, ligatures, clips, barbs, adhesives (silicone, siloxane polymer, fluorosilicones, polycarbonate urethanes, functional equivalent thereof, and/or combinations thereof); functional equivalent thereof, and/or combinations thereof.
  • a graft sleeve and corresponding stent segment(s) may comprise a single integral structure.
  • an end of a graft sleeve and the corresponding stent segment may extend longitudinally substantially equally (as shown in the Figures), the graft sleeve may extend longitudinally beyond the stent segment, or the stent segment may extend longitudinally beyond the graft sleeve.
  • a graft sleeve may be adapted to engage an endoluminal vessel surface by endoluminal cellular invasion (by manipulation of graft sleeve porosity or other equivalent technique), thereby substantially fixing the graft sleeve to the vessel and forming a substantially fluid-tight seal therewith.
  • a substantially fluid-tight seal between a stent graft and a vessel may be achieved by adapting the graft sleeve and corresponding stent segment to engage the endoluminal surface of the vessel. This may be readily achieved by using a graft sleeve outside the stent segment. Expansion of the stent segment (either elastic or plastic) may then serve to press the graft sleeve against the inner vessel surface, thereby forming the substantially fluid-tight seal.
  • a substantially fluid-tight connection between the stent segment and the graft sleeve is required, thereby resulting in a substantially fluid-tight seal between the graft sleeve and vessel surface when the stent segment engages the vessel surface.
  • many other functionally equivalent configurations may be contrived for operatively coupling a graft sleeve to a stent segment, and for engaging an endoluminal surface of the vessel and forming a substantially fluid-tight seal therewith.
  • Internal graft channel 260 and partition 280 may be formed in a variety of functionally equivalent ways without departing from inventive concepts disclosed and/or claimed herein. As shown in FIGS. 1-15 , internal graft channel 260 may be formed by securing an elongated sheet of graft sleeve material to the inner surface of graft sleeve 200 with substantially fluid-tight seams along each side edge of the sheet and along one end of the sheet, with the sheet serving as partition 280 . Alternatively, an internal graft sleeve having open inner and outer ends may be secured longitudinally to the inner surface of graft sleeve 200 ( FIGS. 18-22 ).
  • the internal graft sleeve may be secured along one or more longitudinal seams 285 , and/or at one or more discrete contact points.
  • the open inner end 270 of the internal sleeve may preferably be secured to the inner surface of graft sleeve 200 while remaining open, thereby facilitating subsequent insertion of secondary stent graft 300 thereinto.
  • the sides of the internal graft sleeve serve as partition 280 .
  • the outer open end of the internal graft sleeve may be secured around its perimeter to side opening 250 of graft sleeve 200 to form a substantially fluid-tight seal.
  • the outer end of the internal graft sleeve may be adapted to facilitate communicating with and securing to side opening 250 in a variety of ways, including but not limited to: enlarging the outer end of the internal graft sleeve ( FIG. 23 ); providing the outer end with a diagonal opening ( FIGS. 23 and 24 ); providing the internal graft sleeve with a side opening 284 near the outer end thereof (the outer end itself would then preferably be closed; FIG. 25 ); functionally equivalent methods; and/or combinations thereof.
  • Seams and/or contact points for securing two graft sleeves together and/or securing a sheet of graft sleeve material to a graft sleeve may be accomplished by any suitable technique (extant or hereafter developed), including but not limited to: sutures, ligatures, clips, other fasteners, fusion bonding, electronic welding, thermal bonding, thermal welding, chemical welding, adhesives, functional equivalents thereof, and/or combinations thereof.
  • FIGS. 26-31 illustrate an embodiment of primary stent graft 100 in which the internal primary graft channel 260 is formed by securing together, along a substantially longitudinal seam 282 , portions of an inner surface of the primary graft sleeve 200 separated by a circumferential seam spacing.
  • the first end of the seam 282 extends toward the first end 230 of the primary graft sleeve 200 beyond the side opening 250
  • the second end of the seam 282 extends toward the second end 240 of the primary graft sleeve 200 beyond the side opening 250 .
  • the circumferential seam spacing decreases to substantially zero at the second end of the seam, and the side opening 250 lies within the circumferential seam spacing.
  • Secondary stent graft 300 may be inserted through internal primary graft channel 260 , out through side opening 250 , and into the branch vessel in substantially the same manner as described hereinabove.
  • FIGS. 35-41 illustrate an embodiment of a bifurcated stent graft in which multiple side openings 250 are provided in the primary graft sleeve 200 , each as an circumferential slit in the graft sleeve. A portion of the graft sleeve adjacent the slit is pushed inward, producing an opening.
  • An external primary graft channel 262 is formed by securing (by suturing, thermal bonding, or other suitable techniques) additional graft material to the outer surface of the primary graft sleeve 200 .
  • the additional graft material may take the form of a sleeve 282 the exterior of the primary graft sleeve 200 (as shown in FIGS.
  • the external graft channel 262 thus formed communicates with interior of the primary graft sleeve 200 (i.e., with the primary graft channel 235 ) through the opening 250 in the primary graft sleeve 200 , and provides a fluid flow channel 262 between the primary graft channel 235 through the primary graft sleeve 200 .
  • FIG. 262 Three such external primary graft channels 262 are shown in the Figures at varying longitudinal and circumferential positions.
  • This exemplary arrangement might be suitable for a stent graft in the abdominal aorta spanning the branch points of the renal arteries and superior mesenteric arteries, for example.
  • Other numbers and/or arrangements of the external primary graft channels may be employed that may be suitable for other stent graft locations while remaining within the scope of the present invention.
  • This embodiment may be more readily fabricated than others since all seams may be made on the exterior surface of the primary graft sleeve.
  • the primary graft sleeve 200 shown in FIGS. 35-41 may be provided with stent segments 210 / 220 near the ends 230 / 240 thereof and with stent coupling members 215 as disclosed hereinabove.
  • Each external primary graft channel 262 is shown with a stent segment 292 for providing structural support and for keeping the opening 250 through the primary graft sleeve 200 open.
  • a hexagonal wire mesh extending along substantially the entire length of the external primary graft channel is shown, but other stent configurations may be equivalently employed (including separate first and second stent segments positioned within the external primary graft channel near the ends thereof [with or without a stent coupling member], a single stent segment within the external primary graft channel near the primary graft sleeve opening, or other suitable arrangements).
  • the primary stent graft 100 is shown with a secondary stent graft 300 positioned in and extending from each of the external primary graft channels 262 .
  • the secondary stent grafts 300 may preferably include a secondary graft sleeve 302 and secondary stent segments 310 / 320 within the secondary graft sleeve 302 near the ends thereof.
  • the stent segments 310 / 320 may be separate (as in FIG. 15 ), may be connected by stent segment coupling members 315 (as in FIG. 34 ), or may comprise the ends of a single stent extending substantially the entire length of the secondary graft sleeve 302 (not shown).
  • the primary stent graft 100 may therefore span a damaged portion of the vessel (including any branch points).
  • the side opening(s) 250 and external primary graft channel(s) 262 therefore communicate with a fluid volume that is substantially isolated from intravascular volumes both upstream and downstream of the primary stent graft.
  • One or more secondary stent grafts 300 may be deployed through corresponding side opening(s) 250 , into corresponding external primary graft channel(s) 262 , and into corresponding branch vessel(s) (as in FIG. 17 ).
  • the proximal end 330 of a secondary stent graft 300 thus deployed forms a substantially fluid-tight seal within the corresponding external primary graft channel 262 , while the distal end 340 forms a substantially fluid-tight seal within the branch vessel.
  • a blood flow channel is thereby provided from the primary graft channel 235 into the AAHbranch vessel, while substantially isolating the damaged portion of the vessel (including the branch point) from intravascular fluid pressure.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Prostheses (AREA)

Abstract

A bifurcated intravascular stent graft comprises primary stent segments and a primary graft sleeve, forming a main fluid channel and having a side opening therethrough. An external graft channel formed on the primary graft sleeve has a first end communicating with the side opening and an open second end outside the primary graft sleeve, thereby providing a branch flow channel from the main channel out through the side opening and external graft channel. The primary stent segments and graft sleeve engage an endoluminal surface of a main vessel and form substantially fluid-tight seals. The stent graft further comprises a secondary stent graft, which may be positioned partially within the external graft channel, through the open second end thereof, and partially within a branch vessel. The secondary stent graft engages the inner surface of the external graft channel and the endoluminal surface of the branch vessel, thereby forming substantially fluid-tight seals.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of co-pending U.S. patent application Ser. No. 11/971,426, entitled “Bifurcated Side-Access Intravascular Stent Graft” and filed Jan. 9, 2008, which is a division of U.S. application Ser. No. 10/277,641 filed Oct. 22, 2002, which is a continuation-in-part of U.S. application Ser. No. 09/734,987 filed Dec. 11, 2000, now issued U.S. Pat. No. 6,645,242, the content of which is hereby incorporated by reference in its entirety.
  • BACKGROUND
  • 1. Field
  • The field of the present invention relates to intravascular stent grafts. In particular, a bifurcated side-access intravascular stent graft and methods for fabricating and deploying the same are described herein.
  • 2. Discussion
  • In many instances of vascular disease, a damaged, weakened, and/or enlarged portion of a blood vessel must be protected from intravascular fluid pressure. Continued exposure to such fluid pressure may result in progression of damage to the affected area and/or vessel failure, accompanied by significant morbidity or even sudden death. A well-established technique for treating such vascular damage is the use of transluminally-deployed stent grafts.
  • Briefly, a stent graft comprises two major components, a stent and a graft. The stent (one or more) typically takes the form of a somewhat stiff tube-like structure inserted into an affected vessel and fixed in place. The stent may serve to maintain a patent vessel lumen, may serve as structural support for the vessel, and/or may serve as an attachment/seal for a graft. A graft typically takes the form of a flexible tube or sleeve which is at least somewhat fluid-tight (although varying degrees of permeability may be desirable for a variety of reasons). When secured within a vessel using stents (a single stent the length of the graft, a pair of stent segments at the ends of the graft, or multiple stent segments spaced along the length of the graft), the graft becomes a surrogate vessel-within-a-vessel, and bears the brunt of the intravascular fluid pressure. It has become common practice to bridge damaged vessel segment using a sufficiently long graft secured within the vessel with stent segments.
  • Complications arise, however, when vessel damage occurs near a vessel branch point. More elaborate, multi-component devices are required to both shield the damaged vessel portion while maintaining blood flow through the main and branch vessels. Such devices are described in the following patents and references cited therein. Each of the following patents is hereby incorporated by reference as if fully set forth herein: U.S. Pat. No. 5,906,641; U.S. Pat. No. 6,093,203; U.S. Pat. No. 5,855,598; U.S. Pat. No. 5,972,023; U.S. Pat. No. 6,129,756; U.S. Pat. No. 5,824,040; U.S. Pat. No. 5,628,787; and U.S. Pat. No. 5,957,974.
  • Many of the prior-art devices are suitable for vessel branches where the branch vessel leaves the main vessel at a relatively small angle (less than about 45°, or example). For larger branching angles (as large as about 90° or even up to about 180°, for example) many prior art devices are not suitable. Such large branching angles occur at several potentially important repair sites (particularly along the abdominal aorta, at the renal arteries, celiac artery, superior and inferior mesenteric arteries, for example). Another drawback common to many devices of the prior-art is the need for transluminal access through the branch vessel from a point distal of the repair site. In many instances such access is either impossible (celiac artery, mesenteric arteries, renal arteries) or extremely difficult and/or dangerous (carotid arteries). Still other previous devices do not provide a substantially fluid-tight seal with the branch vessel, thereby partially defeating the purpose of the stent graft (i.e., shielding the repaired portion of the main vessel and/or branch vessel from intravascular fluid pressure).
  • It is therefore desirable to provide a bifurcated side-access intravascular stent graft and methods for fabricating and deploying the same, wherein the stent graft may be deployed transluminally to repair vessels having large-angle branch vessels (ranging from about 0° up to about 180°, for example). It is therefore desirable to provide a bifurcated side-access intravascular stent graft and methods for fabricating and deploying the same, providing a substantially fluid-tight seal with the main vessel and the branch vessel. It is therefore desirable to provide a bifurcated side-access intravascular stent graft and methods for fabricating and deploying the same, wherein the stent graft may be deployed transluminally without distal access through the branch vessel. It is therefore desirable to provide a bifurcated side-access intravascular stent graft and methods for fabricating and deploying the same, wherein the stent graft may be readily and accurately positioned relative to the branch vessel.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The accompanying drawings are included to provide a further understanding of the invention and are incorporated in and constitute a part of this specification, illustrate embodiments of the invention, and together with the description serve to explain the principles of the invention.
  • FIG. 1 shows an isometric view of a primary stent graft according to the present invention.
  • FIG. 2 shows a front view of a primary stent graft according to the present invention.
  • FIG. 3 shows a side view of a primary stent graft according to the present invention.
  • FIG. 4 shows a transverse-sectional view of a primary stent graft according to the present invention.
  • FIG. 5 shows a transverse-sectional view of a primary stent graft according to the present invention.
  • FIG. 6 shows a transverse-sectional view of a primary stent graft according to the present invention.
  • FIG. 7 shows a transverse-sectional view of a primary stent graft according to the present invention.
  • FIG. 8 shows a longitudinal-sectional view of a primary stent graft according to the present invention.
  • FIG. 9 shows a longitudinal-sectional view of a primary stent graft according to the present invention.
  • FIG. 10 shows an isometric view of a bifurcated stent graft according to the present invention.
  • FIG. 11 shows a front view of a bifurcated stent graft according to the present invention.
  • FIG. 12 shows a side view of a bifurcated stent graft according to the present invention.
  • FIG. 13 shows a transverse-sectional view of a bifurcated stent graft according to the present invention.
  • FIG. 14 shows a transverse-sectional view of a bifurcated stent graft according to the present invention.
  • FIG. 15 shows a longitudinal-sectional view of a bifurcated stent graft according to the present invention.
  • FIG. 16 shows a procedure for deploying a primary stent graft according to the present invention.
  • FIG. 17 shows a procedure for deploying a secondary stent graft according to the present invention.
  • FIG. 18 shows a longitudinal-sectional view of a primary stent graft according to the present invention.
  • FIG. 19 shows a transverse-sectional view of a primary stent graft according to the present invention.
  • FIG. 20 shows a transverse-sectional view of a primary stent graft according to the present invention.
  • FIG. 21 shows a transverse-sectional view of a primary stent graft according to the present invention.
  • FIG. 22 shows a transverse-sectional view of a primary stent graft according to the present invention.
  • FIG. 23 shows a procedure for adapting an internal graft sleeve according to the present invention.
  • FIG. 24 shows a procedure for adapting an internal graft sleeve according to the present invention.
  • FIG. 25 shows a transverse-sectional view of a primary stent graft according to the present invention.
  • FIG. 26 shows a front view of a bifurcated stent graft according to the present invention.
  • FIG. 27 shows a side view of a bifurcated stent graft according to the present invention.
  • FIG. 28 shows a transverse-sectional view of a bifurcated stent graft according to the present invention.
  • FIG. 29 shows a transverse-sectional view of a bifurcated stent graft according to the present invention.
  • FIG. 30 shows a transverse-sectional view of a bifurcated stent graft according to the present invention.
  • FIG. 31 shows a transverse-sectional view of a bifurcated stent graft according to the present invention.
  • FIG. 32 shows a transverse-sectional view of a bifurcated stent graft according to the present invention.
  • FIG. 33 shows a transverse-sectional view of a bifurcated stent graft according to the present invention.
  • FIG. 34 shows a longitudinal-sectional view of a bifurcated stent graft according to the present invention.
  • FIG. 35 shows an isometric view of a primary stent graft according to the present invention.
  • FIG. 36 shows an isometric view of a bifurcated stent graft according to the present invention.
  • FIG. 37 shows a front view of a primary stent graft according to the present invention.
  • FIG. 38 shows a transverse-sectional view of a primary stent graft according to the present invention.
  • FIG. 39 shows a transverse-sectional view of a primary stent graft according to the present invention.
  • FIG. 40 shows a transverse-sectional view of a primary stent graft according to the present invention.
  • FIG. 41 shows a longitudinal-sectional view of a primary stent graft according to the present invention.
  • The embodiments shown in the Figures are exemplary, and should not be construed as limiting the scope of the present invention as disclosed and/or claimed herein.
  • DETAILED DESCRIPTION OF THE ILLUSTRATED EMBODIMENTS
  • For purposes of the present written description and/or claims, “proximal” shall denote the direction along a vessel system in which multiple smaller vessels come together to form a larger vessel, and “distal” shall denote the opposite direction, i.e., the direction in which a larger vessel divides into multiple smaller vessels. For an arterial system proximal therefore corresponds to “upstream”, while distal corresponds to “downstream”. It should be noted that for a venous system or a lymphatic system, the correspondence would be reversed. The correspondence may vary for other vascular or duct systems.
  • A bifurcated intravascular primary stent graft 100 according to the present invention is illustrated in FIGS. 1-9 and comprises: a first primary stent segment 210; a second primary stent segment 220; a primary graft sleeve 200 having first open end 230, having a second open end 240, forming a main fluid flow channel 235 therebetween, and having a side opening 250 therethrough; and an internal graft channel 260 formed by partition 280 within the primary graft sleeve 200 and having an inner open end 270 within the primary graft sleeve 200 and an outer open end communicating with the side opening 250 of the primary graft sleeve 200. An internal stent segment 290 may be provided near the inner open end 270 of internal graft channel 260, to keep internal graft channel 260 open and to facilitate later deployment of a secondary stent graft (described herein below). The internal graft channel 260 and partition 280 thereby form at least a portion of a branch fluid flow channel between main channel 235 and the side opening 250 of the primary graft sleeve 200. Primary graft sleeve 200 may be operatively coupled near the first open end 230 to the first primary stent segment 210 and operatively coupled near the second open end 240 to the second primary stent segment 220, so that stent segments 210 and 220 and graft sleeve 200 thereby form a single operative unit. Each stent segment and the corresponding open end may preferably be adapted for engaging an endoluminal surface of a main vessel and forming a substantially fluid-tight seal therewith.
  • A bifurcated intravascular stent graft according to the present invention may comprise a primary stent graft 100 and may further comprise a secondary stent graft 300 as illustrated in FIGS. 10-15. The secondary stent graft 300 comprises: a first secondary stent segment 310; a second secondary stent segment 320; and a secondary graft sleeve 302. Secondary graft sleeve 302 may be operatively coupled near first open end 330 to the first secondary stent segment 310 and operatively coupled near second open end 340 to the second secondary stent segment 320, so that stent segments 310 and 320 and secondary graft sleeve 302 thereby form a single operative unit. Secondary stent 300 may be adapted to pass within internal graft channel 260 and through side opening 250. First stent segment 310 and corresponding first open end 330 may preferably be adapted for engaging an inner surface of internal graft channel 260 and forming a substantially fluid-tight seal therewith. Second stent segment 320 and corresponding second open end 340 may preferably be adapted for engaging an endoluminal surface of a branch vessel and forming a substantially fluid-tight seal therewith. Secondary stent graft 300 may therefore form at least a portion of the branch fluid flow channel.
  • The stent graft of the present invention is particularly well-suited for repair of main vessel segments where a branch vessel leaves the main vessel at an angle approaching 90°. Previous bifurcated stent graft devices enable repairs where a branch vessel leaves the main vessel at a substantially smaller angle of less than about 45°. This condition does not obtain at several potentially important vessel repair sites. Other previous devices enable repair at such high-angled branches only when transluminal access to a distal portion of the branch vessel is possible. In many instances such access is either impossible (celiac artery, mesenteric arteries, renal arteries) or extremely difficult and/or dangerous (carotid arteries). Still other previous devices do not provide a substantially fluid-tight seal with the branch vessel, thereby partially defeating the purpose of the stent graft (i.e., shielding the repaired portion of the main vessel and/or branch vessel from intravascular fluid pressure).
  • The stent graft of the present invention, in contrast, addresses these issues. As shown in FIG. 16, bifurcated primary stent graft 100 may be delivered transluminally to a repair site 30 of a main vessel 20, and may be adjusted longitudinally and/or rotated about its long axis within the main vessel lumen until side opening 250 is substantially aligned with the lumen of branch vessel 40. Bifurcated primary stent graft 100 may be provided with one or more radiopaque markers or indexes to facilitate the alignment under fluoroscopic imaging. First primary stent segment 210 and first open end 230 may be engaged with the endoluminal surface of a first segment of the main vessel 20 near the repair site to form a substantially fluid-tight seal, and second primary stent segment 220 and second open end 240 may be engaged with the endoluminal surface of a second segment of the main vessel 20 near the repair site to form a substantially fluid-tight seal, thereby deploying bifurcated primary stent graft 100 within the repair site 30 of main vessel 20. Bifurcated primary stent graft 100 may be delivered through the main vessel from upstream or from downstream, as dictated by the particular clinical circumstances.
  • After delivery and deployment of bifurcated primary stent graft 100 at the repair site 30, secondary stent graft 300 is then delivered to the repair site and deployed, as illustrated in FIG. 17. Secondary stent graft 300 is delivered transluminally to the repair site and passed within internal graft channel 260 of primary stent graft 100. Secondary stent graft 300 may be delivered within the main vessel to the repair site from the same direction as primary stent graft 100, or from the opposite direction if feasible and/or desirable. Delivery from the same direction as delivery of primary stent graft 100 within the main vessel may be preferred due to the preferred construction of internal graft channel 260. Secondary stent graft 300 may also be delivered from a distal point within the branch vessel 40 if feasible and/or desirable. Secondary stent graft 300 is positioned at least partially within internal graft channel 260, passing through side opening 250 and into branch vessel 40. Secondary stent graft 300 may be provided with one or more radiopaque markers or indexes to facilitate the positioning under fluoroscopic imaging. First secondary stent segment 310 and first open end 330 may be engaged with the inner surface of the internal graft channel 260 to form a substantially fluid-tight seal, and second secondary stent segment 320 and second open end 340 may be engaged with the endoluminal surface of the branch vessel 40 to form a substantially fluid-tight seal, thereby deploying secondary stent graft 300 within the internal graft channel 260 and the branch vessel 40. When deployed together in this way, the first and second substantially fluid-tight seals of primary stent graft 100 and secondary stent graft 300 together substantially shield the main vessel walls and/or the branch vessel walls at the repair site from intravascular fluid pressure, while preserving fluid flow both through the main vessel and into the branch vessel.
  • Once deployed, incoming fluid flow (i.e., arterial or venous blood flow in the typical deployment scenario) may enter either open end 230 or 240 of bifurcated stent graft 100 and pass through main fluid flow channel 235. Upon reaching the inner open end 270 of internal graft channel 260, the incoming fluid flow divides into a portion continuing to flow in the main fluid flow channel 235 and a portion flowing through the branch fluid flow channel within internal graft channel 260 and through side opening 250. The fluid flow in main channel 235 continues out of bifurcated stent graft 100 and back into the main vessel 20. The branch fluid flow channel comprises a portion of internal graft channel 260 and the interior of secondary stent graft 300, and the branch fluid flow passes into the open inner end 270 of internal graft channel 260, into the open first end 330 of secondary stent graft 300, through secondary stent graft 300 (and therefore through side opening 250), out of open second end 340 of secondary stent graft 300, and into branch vessel 40. Stent graft 300 may preferably be made sufficiently flexible to be bent through angles ranging from about 0° through about 180° while still forming a portion of the branch fluid flow channel. In this way the bifurcated stent graft of the present invention may be used to repair main vessels near where branch vessels leave the main vessel at arbitrarily large angles, even approaching about 180°. To facilitate longitudinal and/or rotational alignment of bifurcated primary stent graft 100 relative to the lumen of the branch vessel, side opening 250 through primary graft sleeve 200 may be made substantially larger than the lumen, thereby increasing the range of positions of bifurcated primary stent graft 100 that nevertheless enable passing secondary stent graft 300 through side opening 250 and into branch vessel 40. It may be desirable for internal graft channel 260 to increase in size with distance from inner open end 270, so that the size of the open inner end of internal graft channel 260 may substantially match the size of secondary stent graft 300 and/or the lumen of branch vessel 40, while the outer open end of internal graft channel 260 may substantially match the relatively enlarged size of side opening 250.
  • Without departing from inventive concepts disclosed and/or claimed herein, any suitable configuration and/or materials (currently known or hereafter developed) may be employed for stent segments 210, 220, 290, 310, and/or 320. Many suitable configurations for intravascular stents have been developed over the years, as disclosed in the incorporated references and in references cited therein (U.S. Pat. Nos. 5,855,598 and 6,093,203 are of particular note for containing many examples). Such stent configurations may include but are not limited to braids (open-lattice or closely-woven), helical structural strands, sinusoidal structural strands, mesh-like materials, diamond-shaped mesh, rectangular shaped mesh, functional equivalents thereof, and/or combinations thereof. Materials should be sufficiently strong, bio-compatible, hemo9 compatible, corrosion-resistant, and fatigue-resistant, and may include metals, plastics, stainless steels, stainless spring steels, cobalt-containing alloys, titanium-containing alloys, nitinol, nickel-containing alloys, nickel-titanium alloys, composite materials, clad composite materials, other functionally equivalent materials (extant or hereafter developed), and/or combinations thereof. Whatever its construction, a stent graft may typically be delivered transluminally to a vascular repair site with the stent segment in a radially compressed configurations having a delivery diameter sufficiently small to pass through any required vessels to the repair site. Once positioned properly, the stent segment may be radially enlarged to a deployed diameter. The stent segment may be fabricated so that the delivery diameter is achieved through elastic radial compression of the stent segment (maintained during transluminal delivery by a sleeve or equivalent device). Once properly positioned, the sleeve or equivalent device may be removed, thereby allowing the stent segment to expand to its deployed diameter. The deployed diameter may be smaller than the uncompressed diameter of the stent segment, so that residual elastic expanding force exerted by the stent segment may serve to hold the vessel open, fix the stent in place in the vessel, and/or form a substantially fluid-tight seal with the endoluminal surface of the vessel (in conjunction with a graft sleeve). Alternatively, the stent segment may comprise material(s) that undergo plastic deformation. The stent graft may be delivered transluminally with the stent segment having a delivery diameter sufficiently small to allow delivery to the repair site. The stent segment may then be expanded (by an intra-luminal balloon catheter or other functionally equivalent device) to a deployed diameter, and may maintain the deployed diameter due to plastic deformation of the stent segment during expansion. The expanded stent segment may serve to engage the endoluminal surface of the vessel to hold the vessel open, hold the stent graft in position, and/or form a substantially fluid-tight seal with the vessel. Other methods of delivery and/or deployment may be employed without departing from inventive concepts disclosed and/or claimed herein.
  • Whatever configuration of stent segment(s) is employed, the stent segment must be adapted to engage the endoluminal surface of the vessel. This may be accomplished by any suitable method (currently known or hereafter developed; for example as disclosed in the incorporated references and in references cited therein), including but not limited to: elastic or plastic expansion; sutures; ligatures; clips; barbs; endoluminal cellular overgrowth; functional equivalents thereof; and/or combinations thereof.
  • First and second stent segments corresponding to a single graft sleeve of a single stent graft have been shown herein as separate structural elements. Pairs of first and second stent segments ( segments 210 and 220, for example, or 310 and 320) may be mechanically connected by a stent coupling member. Three longitudinal wires 215 are shown serving to connect stent segments 210 and 220 of primary stent graft 100, while longitudinal wires 315 are shown serving to connect stent segments 310 and 320 in FIGS. 32, 33, and 34. Other functionally equivalent configurations may be employed without departing from inventive concepts disclosed and/or claimed herein. In particular, it may be desirable for corresponding first and second stent segments to comprise first and second ends of a single stent. In the case of stent segments 210 and 220, a single primary stent would require an side opening corresponding to side opening 250 of graft sleeve 200. No such side opening would be required for a single secondary stent comprising first and second segments 310 and 320. Such a single stent may be preferred for secondary stent graft 300, since it is typically bent to enter a branch vessel but must nevertheless maintain an open branch fluid channel.
  • Without departing from inventive concepts disclosed and/or claimed herein, any suitable configuration and/or materials (currently known or hereafter developed) may be employed for primary graft sleeve 200, partition 280, and/or graft sleeve 300. Such sleeve materials may include, but are not limited to: continuous sheets; interwoven textile strands; multiple filament yarns (twisted or un-twisted); monofilament yarns; PET (Dacron), polypropylene, polyethylene, high-density polyethylene, polyurethane, silicone, PTFE, polyolefins, ePTFE, biologically-derived membranes (such as swine intestinal submucosa), functional equivalents thereof, and/or combinations thereof. The graft sleeve may be delivered at the size appropriate for deployment at the repair site, or may be a smaller size and stretched (plastically deformed) at the repair site to the desired deployed size. Graft sleeves are shown herein outside the corresponding stent segment, but the stent segment may equivalently be outside the corresponding graft sleeve. The graft sleeve and corresponding stent segment(s) may be operatively coupled by any suitable method (currently known or hereafter developed), including but not limited to: sutures, ligatures, clips, barbs, adhesives (silicone, siloxane polymer, fluorosilicones, polycarbonate urethanes, functional equivalent thereof, and/or combinations thereof); functional equivalent thereof, and/or combinations thereof. Alternatively, a graft sleeve and corresponding stent segment(s) may comprise a single integral structure. Without departing from inventive concepts disclosed and/or claimed herein, an end of a graft sleeve and the corresponding stent segment may extend longitudinally substantially equally (as shown in the Figures), the graft sleeve may extend longitudinally beyond the stent segment, or the stent segment may extend longitudinally beyond the graft sleeve. Without departing from inventive concepts disclosed and/or claimed herein, a graft sleeve may be adapted to engage an endoluminal vessel surface by endoluminal cellular invasion (by manipulation of graft sleeve porosity or other equivalent technique), thereby substantially fixing the graft sleeve to the vessel and forming a substantially fluid-tight seal therewith.
  • In the present invention, a substantially fluid-tight seal between a stent graft and a vessel may be achieved by adapting the graft sleeve and corresponding stent segment to engage the endoluminal surface of the vessel. This may be readily achieved by using a graft sleeve outside the stent segment. Expansion of the stent segment (either elastic or plastic) may then serve to press the graft sleeve against the inner vessel surface, thereby forming the substantially fluid-tight seal. For a graft sleeve inside the stent segment, a substantially fluid-tight connection between the stent segment and the graft sleeve is required, thereby resulting in a substantially fluid-tight seal between the graft sleeve and vessel surface when the stent segment engages the vessel surface. Without departing from inventive concepts disclosed and/or claimed herein, many other functionally equivalent configurations (currently known or hereafter developed) may be contrived for operatively coupling a graft sleeve to a stent segment, and for engaging an endoluminal surface of the vessel and forming a substantially fluid-tight seal therewith.
  • Internal graft channel 260 and partition 280 may be formed in a variety of functionally equivalent ways without departing from inventive concepts disclosed and/or claimed herein. As shown in FIGS. 1-15, internal graft channel 260 may be formed by securing an elongated sheet of graft sleeve material to the inner surface of graft sleeve 200 with substantially fluid-tight seams along each side edge of the sheet and along one end of the sheet, with the sheet serving as partition 280. Alternatively, an internal graft sleeve having open inner and outer ends may be secured longitudinally to the inner surface of graft sleeve 200 (FIGS. 18-22). The internal graft sleeve may be secured along one or more longitudinal seams 285, and/or at one or more discrete contact points. The open inner end 270 of the internal sleeve may preferably be secured to the inner surface of graft sleeve 200 while remaining open, thereby facilitating subsequent insertion of secondary stent graft 300 thereinto. The sides of the internal graft sleeve serve as partition 280. The outer open end of the internal graft sleeve may be secured around its perimeter to side opening 250 of graft sleeve 200 to form a substantially fluid-tight seal. The outer end of the internal graft sleeve may be adapted to facilitate communicating with and securing to side opening 250 in a variety of ways, including but not limited to: enlarging the outer end of the internal graft sleeve (FIG. 23); providing the outer end with a diagonal opening (FIGS. 23 and 24); providing the internal graft sleeve with a side opening 284 near the outer end thereof (the outer end itself would then preferably be closed; FIG. 25); functionally equivalent methods; and/or combinations thereof. Seams and/or contact points for securing two graft sleeves together and/or securing a sheet of graft sleeve material to a graft sleeve and may be accomplished by any suitable technique (extant or hereafter developed), including but not limited to: sutures, ligatures, clips, other fasteners, fusion bonding, electronic welding, thermal bonding, thermal welding, chemical welding, adhesives, functional equivalents thereof, and/or combinations thereof.
  • FIGS. 26-31 illustrate an embodiment of primary stent graft 100 in which the internal primary graft channel 260 is formed by securing together, along a substantially longitudinal seam 282, portions of an inner surface of the primary graft sleeve 200 separated by a circumferential seam spacing. The first end of the seam 282 extends toward the first end 230 of the primary graft sleeve 200 beyond the side opening 250, while the second end of the seam 282 extends toward the second end 240 of the primary graft sleeve 200 beyond the side opening 250. The circumferential seam spacing decreases to substantially zero at the second end of the seam, and the side opening 250 lies within the circumferential seam spacing. In this way a single graft sleeve 200 may be used to provide both main and branch fluid flow channels, thereby simplifying manufacture of the bifurcated stent graft. Secondary stent graft 300 may be inserted through internal primary graft channel 260, out through side opening 250, and into the branch vessel in substantially the same manner as described hereinabove.
  • FIGS. 35-41 illustrate an embodiment of a bifurcated stent graft in which multiple side openings 250 are provided in the primary graft sleeve 200, each as an circumferential slit in the graft sleeve. A portion of the graft sleeve adjacent the slit is pushed inward, producing an opening. An external primary graft channel 262 is formed by securing (by suturing, thermal bonding, or other suitable techniques) additional graft material to the outer surface of the primary graft sleeve 200. The additional graft material may take the form of a sleeve 282 the exterior of the primary graft sleeve 200 (as shown in FIGS. 35-41), or may be provided by securing a strip of graft material along its side edges to the exterior of the primary graft sleeve 200, forming the external primary graft channel 262 between the strip and the primary graft sleeve 200. In either case, the external graft channel 262 thus formed communicates with interior of the primary graft sleeve 200 (i.e., with the primary graft channel 235) through the opening 250 in the primary graft sleeve 200, and provides a fluid flow channel 262 between the primary graft channel 235 through the primary graft sleeve 200. Three such external primary graft channels 262 are shown in the Figures at varying longitudinal and circumferential positions. This exemplary arrangement might be suitable for a stent graft in the abdominal aorta spanning the branch points of the renal arteries and superior mesenteric arteries, for example. Other numbers and/or arrangements of the external primary graft channels may be employed that may be suitable for other stent graft locations while remaining within the scope of the present invention. This embodiment may be more readily fabricated than others since all seams may be made on the exterior surface of the primary graft sleeve.
  • The primary graft sleeve 200 shown in FIGS. 35-41 may be provided with stent segments 210/220 near the ends 230/240 thereof and with stent coupling members 215 as disclosed hereinabove. Each external primary graft channel 262 is shown with a stent segment 292 for providing structural support and for keeping the opening 250 through the primary graft sleeve 200 open. A hexagonal wire mesh extending along substantially the entire length of the external primary graft channel is shown, but other stent configurations may be equivalently employed (including separate first and second stent segments positioned within the external primary graft channel near the ends thereof [with or without a stent coupling member], a single stent segment within the external primary graft channel near the primary graft sleeve opening, or other suitable arrangements). In FIG. 36, the primary stent graft 100 is shown with a secondary stent graft 300 positioned in and extending from each of the external primary graft channels 262. The secondary stent grafts 300 may preferably include a secondary graft sleeve 302 and secondary stent segments 310/320 within the secondary graft sleeve 302 near the ends thereof. The stent segments 310/320 may be separate (as in FIG. 15), may be connected by stent segment coupling members 315 (as in FIG. 34), or may comprise the ends of a single stent extending substantially the entire length of the secondary graft sleeve 302 (not shown). When deployed (as in FIG. 16), the primary stent graft 100 of FIG. 35 may form substantially fluid-tight seals with an endoluminal surface of a vessel near the ends of the primary stent graft, by engagement of the stent segments 210/220 with the vessel. The primary stent graft 100 may therefore span a damaged portion of the vessel (including any branch points). The side opening(s) 250 and external primary graft channel(s) 262 therefore communicate with a fluid volume that is substantially isolated from intravascular volumes both upstream and downstream of the primary stent graft. One or more secondary stent grafts 300 may be deployed through corresponding side opening(s) 250, into corresponding external primary graft channel(s) 262, and into corresponding branch vessel(s) (as in FIG. 17). The proximal end 330 of a secondary stent graft 300 thus deployed forms a substantially fluid-tight seal within the corresponding external primary graft channel 262, while the distal end 340 forms a substantially fluid-tight seal within the branch vessel. A blood flow channel is thereby provided from the primary graft channel 235 into the AAHbranch vessel, while substantially isolating the damaged portion of the vessel (including the branch point) from intravascular fluid pressure.
  • It will be apparent to those skilled in the art that various modifications and variations can be made in the present invention without departing from the spirit or scope of the invention. Thus, it is intended that the present invention cover the modifications and variations of this invention provided they come within the scope of the appended claims and their equivalents.

Claims (27)

What is claimed is:
1. A branching intravascular stent graft, comprising: a stent; a primary graft sleeve coupled to the stent, the primary graft sleeve having a first end and a second end, the primary graft sleeve having an opening therethrough between the first and second ends, the primary graft sleeve forming a fluid flow channel; and an internal graft channel formed within the primary graft sleeve and separated from the fluid flow channel by a partition, the internal graft channel having a first open end and a second open end, the second open end of the internal graft channel in fluid communication with the opening in the primary graft sleeve, the internal graft channel capable of allowing branch fluid flow through and between the first open end and the opening of the primary graft sleeve.
2. The stent graft of claim 1 wherein the stent is coupled to the primary graft sleeve near the primary graft sleeve first end.
3. The stent graft of claim 1 wherein the stent is coupled to the primary graft sleeve near the primary graft sleeve second end.
4. The stent graft of claim 1 wherein the stent is coupled to the primary graft sleeve near the primary graft sleeve first end; and an additional stent is coupled to the primary graft sleeve near the primary graft sleeve second end.
5. The stent graft of claim 1 further comprising a secondary stent graft, the secondary stent graft comprising: a secondary stent, a secondary graft sleeve coupled to the stent, the secondary graft sleeve having a first end and a second end, wherein the secondary stent graft is adapted for passing within the internal graft channel.
6. The stent graft of claim 5 wherein the secondary stent is coupled to the secondary graft sleeve near the secondary graft sleeve first end.
7. The stent graft of claim 5 wherein the secondary stent is coupled to the secondary graft sleeve near the secondary graft sleeve second end.
8. The stent graft of claim 5wherein the secondary stent is coupled to the secondary graft sleeve near the secondary graft sleeve first end; and an additional secondary stent is coupled to the secondary graft sleeve near the secondary graft sleeve second end.
9. The stent graft of claim 1 wherein the stent comprises a helical form.
10. The stent graft of claim 1 wherein the stent comprises multiple ring forms.
11. The stent graft of claim 1 wherein the stent essentially spans between the primary graft sleeve first and second ends.
12. The stent graft of claim 11 wherein the stent comprises a helical form.
13. The stent graft of claim 11 wherein the stent comprises multiple ring forms.
14. The stent graft of claim 1 wherein the first open end of the internal graft channel extends longitudinally beyond the primary graft sleeve first end.
15. The stent graft of claim 1 wherein the first open end of the internal graft channel extends beyond the primary graft sleeve second end.
16. The stent graft of claim 1 wherein the primary graft sleeve first end is adapted for engaging a vessel lumen.
17. The stent graft of claim 1 wherein the primary graft sleeve second end is adapted for engaging a vessel lumen.
18. The stent graft of claim 1 wherein the primary graft sleeve first and second ends are adapted for engaging a vessel lumen.
19. The stent graft of claim 2 wherein the stent is adapted for engaging a vessel lumen.
20. The stent graft of claim 3 wherein the stent is adapted for engaging a vessel lumen.
21. The stent graft of claim 4 wherein the stent and additional stent are adapted for engaging a vessel lumen.
22. The stent graft of claim 11 wherein the primary graft sleeve first and second ends are adapted for engaging a vessel lumen.
23. The stent graft of claim 11 wherein the stent is adapted for engaging a vessel lumen near the primary graft sleeve first and second ends.
24. The stent graft of claim 1 further comprising at least one additional internal graft channel formed within the primary graft sleeve and separated from the fluid flow channel by a partition, the at least one additional internal graft channel having a first open end and a second open end, the second open end of the at least one additional internal graft channel in fluid communication with an at least one additional opening in the primary graft sleeve between the first and second ends of the primary graft sleeve, the at least one additional internal graft channel capable of allowing branch fluid flow through and between the first open end of the at least one additional internal graft channel and the at least one additional opening in the primary graft sleeve between the first and second ends of the primary graft sleeve.
25. The stent graft of claim 1 further comprising at least one radiopaque marker coupled to the stent graft.
26. The stent graft of claim 5 further comprising at least one radiopaque marker coupled to the secondary stent graft.
27. The stent graft of claim 1 wherein the internal graft channel is secured to an inner surface of the primary graft sleeve at one or more discrete contact points.
US13/906,247 2000-12-11 2013-05-30 Bifurcated side-access intravascular stent graft Abandoned US20130274857A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US13/906,247 US20130274857A1 (en) 2000-12-11 2013-05-30 Bifurcated side-access intravascular stent graft
US17/100,345 US20210068992A1 (en) 2002-10-22 2020-11-20 Bifurcated side-access intravascular stent graft
US17/482,120 US20220008230A1 (en) 2002-10-22 2021-09-22 Bifurcated side-access intravascular stent graft

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/734,987 US6645242B1 (en) 2000-12-11 2000-12-11 Bifurcated side-access intravascular stent graft
US27764102A 2002-10-22 2002-10-22
US11/971,426 US8556961B2 (en) 2000-12-11 2008-01-09 Method of deploying a bifurcated side-access intravascular stent graft
US13/906,247 US20130274857A1 (en) 2000-12-11 2013-05-30 Bifurcated side-access intravascular stent graft

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US27764102A Division 2000-12-11 2002-10-22
US11/971,426 Continuation US8556961B2 (en) 2000-12-11 2008-01-09 Method of deploying a bifurcated side-access intravascular stent graft

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US17/100,345 Continuation US20210068992A1 (en) 2002-10-22 2020-11-20 Bifurcated side-access intravascular stent graft

Publications (1)

Publication Number Publication Date
US20130274857A1 true US20130274857A1 (en) 2013-10-17

Family

ID=74849842

Family Applications (3)

Application Number Title Priority Date Filing Date
US13/906,247 Abandoned US20130274857A1 (en) 2000-12-11 2013-05-30 Bifurcated side-access intravascular stent graft
US17/100,345 Abandoned US20210068992A1 (en) 2002-10-22 2020-11-20 Bifurcated side-access intravascular stent graft
US17/482,120 Pending US20220008230A1 (en) 2002-10-22 2021-09-22 Bifurcated side-access intravascular stent graft

Family Applications After (2)

Application Number Title Priority Date Filing Date
US17/100,345 Abandoned US20210068992A1 (en) 2002-10-22 2020-11-20 Bifurcated side-access intravascular stent graft
US17/482,120 Pending US20220008230A1 (en) 2002-10-22 2021-09-22 Bifurcated side-access intravascular stent graft

Country Status (1)

Country Link
US (3) US20130274857A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9936955B2 (en) 2011-01-11 2018-04-10 Amsel Medical Corporation Apparatus and methods for fastening tissue layers together with multiple tissue fasteners
US9987122B2 (en) 2016-04-13 2018-06-05 Medtronic Vascular, Inc. Iliac branch device and method
US10076339B2 (en) 2011-01-11 2018-09-18 Amsel Medical Corporation Method and apparatus for clamping tissue layers and occluding tubular body lumens
US20190029798A1 (en) * 2016-02-04 2019-01-31 Jotec Gmbh Vascular prosthesis with side branches
US10398445B2 (en) 2011-01-11 2019-09-03 Amsel Medical Corporation Method and apparatus for clamping tissue layers and occluding tubular body structures
US10820895B2 (en) 2011-01-11 2020-11-03 Amsel Medical Corporation Methods and apparatus for fastening and clamping tissue
US11523893B2 (en) * 2017-08-28 2022-12-13 Lifetech Scientific (Shenzhen) Co., Ltd Covered stent
US11534318B2 (en) * 2017-07-18 2022-12-27 Cook Medical Technologies Llc Stent graft having an internal bidirectional branch

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024514623A (en) * 2021-04-16 2024-04-02 ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド IMPLANTABLE DEVICES FOR BIFURCATED LUMENS AND ASSOCIATED SYSTEMS AND METHODS - Patent application
WO2024168255A1 (en) * 2023-02-09 2024-08-15 W. L. Gore & Associates, Inc. Stent graft with features for side branch vessel perfusion

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001074270A2 (en) * 2000-03-30 2001-10-11 Teramed Corporation Bifurcated graft and method of delivery
US20030040771A1 (en) * 1999-02-01 2003-02-27 Hideki Hyodoh Methods for creating woven devices
US20030130720A1 (en) * 2002-01-08 2003-07-10 Depalma Donald F. Modular aneurysm repair system

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006034276A1 (en) * 2004-09-21 2006-03-30 William A. Cook Austrialia Pty. Ltd. Side branch stent graft
ATE448754T1 (en) * 2006-08-18 2009-12-15 Cook William A Australia STENT IMPLANT

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030040771A1 (en) * 1999-02-01 2003-02-27 Hideki Hyodoh Methods for creating woven devices
WO2001074270A2 (en) * 2000-03-30 2001-10-11 Teramed Corporation Bifurcated graft and method of delivery
US20030130720A1 (en) * 2002-01-08 2003-07-10 Depalma Donald F. Modular aneurysm repair system

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9936955B2 (en) 2011-01-11 2018-04-10 Amsel Medical Corporation Apparatus and methods for fastening tissue layers together with multiple tissue fasteners
US10076339B2 (en) 2011-01-11 2018-09-18 Amsel Medical Corporation Method and apparatus for clamping tissue layers and occluding tubular body lumens
US10398445B2 (en) 2011-01-11 2019-09-03 Amsel Medical Corporation Method and apparatus for clamping tissue layers and occluding tubular body structures
US10820895B2 (en) 2011-01-11 2020-11-03 Amsel Medical Corporation Methods and apparatus for fastening and clamping tissue
US10918391B2 (en) 2011-01-11 2021-02-16 Amsel Medical Corporation Method and apparatus for clamping tissue and occluding tubular body lumens
US20190029798A1 (en) * 2016-02-04 2019-01-31 Jotec Gmbh Vascular prosthesis with side branches
US10952840B2 (en) * 2016-02-04 2021-03-23 Jotec Gmbh Vascular prosthesis with side branches
US9987122B2 (en) 2016-04-13 2018-06-05 Medtronic Vascular, Inc. Iliac branch device and method
US11534318B2 (en) * 2017-07-18 2022-12-27 Cook Medical Technologies Llc Stent graft having an internal bidirectional branch
US11523893B2 (en) * 2017-08-28 2022-12-13 Lifetech Scientific (Shenzhen) Co., Ltd Covered stent

Also Published As

Publication number Publication date
US20220008230A1 (en) 2022-01-13
US20210068992A1 (en) 2021-03-11

Similar Documents

Publication Publication Date Title
US8870946B1 (en) Method of deploying a bifurcated side-access intravascular stent graft
US6645242B1 (en) Bifurcated side-access intravascular stent graft
US20220008230A1 (en) Bifurcated side-access intravascular stent graft
US7175651B2 (en) Stent/graft assembly
JP4852033B2 (en) Modular endovascular graft
US6152945A (en) Tubular medical graft connectors
EP2152197B1 (en) Apparatus for treatment of aneurysms adjacent to branch arteries
AU669338B2 (en) Expandable transluminal graft prosthesis for repair of aneurysm and method for implanting
AU738826B2 (en) Endovascular prosthetic device, and method of use
US7105017B2 (en) Axially-connected stent/graft assembly
JP4694575B2 (en) Bifurcated vascular graft design and deployment method
US6364901B1 (en) Appliance collapsible for insertion into a human organ and capable of resilient restoration
US8257423B2 (en) Stent/graft assembly
US20070208410A1 (en) Methods and Apparatus for Treatment of Aneurysms Adjacent to Branch Arteries
US20030009212A1 (en) Axially-connected stent/graft assembly
US20050113905A1 (en) Endoluminal prosthesis with interconnectable modules
US20050033406A1 (en) Branch vessel stent and graft
US20040073288A1 (en) Stent/graft assembly
WO1998019630A2 (en) Tubular medical graft connectors
US9956070B2 (en) Percutaneous endovascular apparatus for repair of aneurysms and arterial blockages
CN117084827A (en) Tectorial membrane support, system and application thereof
EP1266635A2 (en) Axially-connected stent/graft assembly
CN221556131U (en) Implantable medical device and implantable medical system
US20240156626A1 (en) Stent with remote manipulation
CN112618122B (en) Vascular stent

Legal Events

Date Code Title Description
STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCV Information on status: appeal procedure

Free format text: NOTICE OF APPEAL FILED

STCV Information on status: appeal procedure

Free format text: APPEAL BRIEF (OR SUPPLEMENTAL BRIEF) ENTERED AND FORWARDED TO EXAMINER

STCV Information on status: appeal procedure

Free format text: EXAMINER'S ANSWER TO APPEAL BRIEF MAILED

STCV Information on status: appeal procedure

Free format text: ON APPEAL -- AWAITING DECISION BY THE BOARD OF APPEALS

STCV Information on status: appeal procedure

Free format text: BOARD OF APPEALS DECISION RENDERED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION